1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Cerebrovascular Disorders in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (23.08) | 18.7374 |
| 1990's | 9 (69.23) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiao, Y; Sun, MY; Tian, X; Wang, DQ; Wang, ZG | 1 |
| Feuerstein, GZ; Hallenbeck, JM; Lindsberg, PJ; Sirén, AL | 1 |
| Satoh, K; Takamatsu, S; Yoshida, H | 1 |
| Feuerstein, G; Hallenbeck, JM; Liu, Y; Sirén, AL | 1 |
| Lithner, F | 1 |
| Benyó, Z; Csáki, C; Kovách, AG; Szabó, C | 1 |
| Doron, D; Feuerstein, G; Hallenbeck, JM; Heldman, E; Liu, Y; Lysko, PG; Sirén, AL; Yue, TL | 1 |
| Grunfeld, S; Han, E; Joseph, R; Welch, KM | 1 |
| Feuerstein, G; Frerichs, KU; Hallenbeck, JM; Lindsberg, PJ; Yue, TL | 1 |
| Feuerstein, G; Lysko, PG; Yue, TL | 1 |
| D'Andrea, G; Joseph, R; Welch, KM | 1 |
| D'Andrea, G; Grunfeld, S; Joseph, R; Oster, SB; Welch, KM | 1 |
| Imaizumi, T; Kawamura, Y; Mizono, S; Satoh, K; Shoji, B; Takamatsu, M; Takamatsu, S; Yoshida, H | 1 |
2 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cerebrovascular Disorders
| Article | Year |
|---|---|
[Stroke, platelet activating factor and receptor antagonists].
Topics: Cerebrovascular Disorders; Humans; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, G-Protein-Coupled; Stroke | 2017 |
Platelet-activating factor. A putative mediator in central nervous system injury?
Topics: Animals; Brain; Cerebrovascular Disorders; Diterpenes; Gerbillinae; Ginkgolides; Lactones; Platelet Activating Factor; Rats; Signal Transduction | 1990 |
11 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Cerebrovascular Disorders
| Article | Year |
|---|---|
Antagonism of neutrophil adherence in the deteriorating stroke model in rabbits.
Topics: Animals; Azepines; Cell Adhesion; Cerebrovascular Disorders; Ischemia; Male; Neutrophils; Platelet Activating Factor; Rabbits; Reperfusion Injury; Spinal Cord; Triazoles | 1995 |
Platelet-activating factor acetylhydrolase in red cell membranes. Does decreased activity impair erythrocyte deformability in ischemic stroke patients?
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Aged; Brain Ischemia; Cerebrovascular Disorders; Erythrocyte Deformability; Erythrocyte Membrane; Female; Humans; Male; Middle Aged; Phospholipases A; Platelet Activating Factor | 1993 |
Increased release of tumor necrosis factor-alpha into the cerebrospinal fluid and peripheral circulation of aged rats.
Topics: Aging; Animals; Cerebrovascular Disorders; Endothelium, Vascular; Inflammation; Injections, Intraventricular; Lipopolysaccharides; Male; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha | 1993 |
Diabetes mellitus and Alzheimer's disease.
Topics: Aged; Alzheimer Disease; Cerebrovascular Disorders; Confusion; Dementia, Multi-Infarct; Diabetes Complications; Diabetes Mellitus; Glucose Tolerance Test; Humans; Incidence; Insulin; Platelet Activating Factor; Reference Values; Sweden | 1996 |
Role of platelet-activating factor in the development of endothelial dysfunction in hemorrhagic hypotension and retransfusion.
Topics: Animals; Azepines; Blood Transfusion; Cats; Cerebrovascular Disorders; Endothelium, Vascular; Hemorrhage; Hypotension; Male; Platelet Activating Factor; Triazoles | 1992 |
Release of proinflammatory and prothrombotic mediators in the brain and peripheral circulation in spontaneously hypertensive and normotensive Wistar-Kyoto rats.
Topics: Animals; Brain; Cerebrovascular Disorders; Dose-Response Relationship, Drug; Hypertension; Injections, Intravenous; Injections, Intraventricular; Leukocyte Count; Lipopolysaccharides; Platelet Activating Factor; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reference Values; Risk Factors; Thromboxane B2; Tumor Necrosis Factor-alpha | 1992 |
[Effect of chronic antiplatelet treatment on platelet activating factor-induced platelet activity in stroke].
Topics: Adenosine Triphosphate; Adult; Aspirin; Calcium; Cerebrovascular Disorders; Female; Humans; Ibuprofen; Male; Middle Aged; Platelet Activating Factor; Platelet Aggregation | 1991 |
Evidence for platelet-activating factor as a novel mediator in experimental stroke in rabbits.
Topics: Animals; Azepines; Cerebrovascular Disorders; Disease Models, Animal; Platelet Activating Factor; Rabbits; Reference Values; Regional Blood Flow; Spinal Cord; Spinal Cord Injuries; Triazoles | 1990 |
Effect of therapy on platelet activating factor-induced aggregation in acute stroke.
Topics: Aspirin; Cerebrovascular Disorders; Dipyridamole; Drug Therapy, Combination; Female; Humans; Male; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors | 1989 |
Cytosolic ionized calcium homeostasis in platelets: an abnormal sensitivity to PAF-activation in migraine.
Topics: Adult; Aged; Blood Platelets; Calcium Channels; Cerebrovascular Disorders; Cytosol; Female; Homeostasis; Humans; Male; Middle Aged; Migraine Disorders; Platelet Activating Factor | 1988 |
Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adenosine Diphosphate; Aged; Aged, 80 and over; Apoproteins; Cerebrovascular Disorders; Enzyme Induction; Female; Humans; Lipids; Male; Middle Aged; Phospholipases; Phospholipases A; Platelet Activating Factor; Platelet Aggregation | 1988 |